MeiraGTx Holdings plc (328.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR

Add to watchlist

4.7200

+0.1600

(+3.51%)

At close: 07:29PM CEST

Loading interactive chart...

GuruFocus.com
MeiraGTx Holdings PLC Reports First Quarter 2024 Financial Results
Performance Aligns with Analyst Projections Amidst Strategic Clinical Advancements
Simply Wall St.
MeiraGTx Holdings First Quarter 2024 Earnings: US$0.32 loss per share (vs US$0.62 loss in 1Q 2023)
MeiraGTx Holdings ( NASDAQ:MGTX ) First Quarter 2024 Results Key Financial Results Revenue: US$697.0k (down 79% from 1Q...
GlobeNewswire
MeiraGTx Reports First Quarter 2024 Financial and Operational Results
- Positive data from the Phase 1 AQUAx study in radiation-induced xerostomia (RIX) presented in an oral session at the American Academy of Oral Medicine 2024 annual meeting (AAOM) April 17-20, 2024 - Received $50 million milestone following initiation of the extension study for the Phase 3 LUMEOS clinical trial for botaretigene sparoparvovec (bota-vec, formerly AAV-RPGR) for the treatment of X-linked retinitis pigmentosa (XLRP) - Clinical development milestones met and remain on track for the re